CytomX Therapeutics Inc (CTMX) — Net Asset Quality Index
CytomX Therapeutics Inc (CTMX) has a Net Asset Quality Index of 79.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $381.23 Million minus total liabilities of $79.16 Million yields net assets of $302.07 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check cash flow quality index of CytomX Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
CytomX Therapeutics Inc Net Asset Quality Index Over Time (2013–2025)
This chart shows how CytomX Therapeutics Inc's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 79.2%, representing net assets of $302.07 Million against total assets of $381.23 Million USD. See shareholders equity of CytomX Therapeutics Inc for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for CytomX Therapeutics Inc (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for CytomX Therapeutics Inc from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CytomX Therapeutics Inc (CTMX) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 65.3% | $99.01 Million | $151.57 Million | $52.56 Million | ▲ +65.7 pp |
| 2024 | -0.4% | $-456.00K | $120.53 Million | $120.99 Million | ▲ +23.1 pp |
| 2023 | -23.5% | $-47.45 Million | $201.79 Million | $249.24 Million | ▲ +9.4 pp |
| 2022 | -32.9% | $-85.75 Million | $260.89 Million | $346.64 Million | ▼ -59.2 pp |
| 2021 | 26.3% | $89.38 Million | $339.41 Million | $250.03 Million | ▲ +28.5 pp |
| 2020 | -2.2% | $-7.77 Million | $358.66 Million | $366.44 Million | ▼ -17.1 pp |
| 2019 | 15.0% | $51.11 Million | $341.28 Million | $290.17 Million | ▼ -13.7 pp |
| 2018 | 28.6% | $130.88 Million | $457.11 Million | $326.23 Million | ▲ +11.1 pp |
| 2017 | 17.6% | $69.90 Million | $397.64 Million | $327.75 Million | ▼ -21.8 pp |
| 2016 | 39.4% | $78.48 Million | $199.13 Million | $120.65 Million | ▼ -24.5 pp |
| 2015 | 63.9% | $126.07 Million | $197.22 Million | $71.15 Million | ▲ +171.4 pp |
| 2014 | -107.5% | $-78.54 Million | $73.06 Million | $151.60 Million | ▲ +204.7 pp |
| 2013 | -312.2% | $-44.28 Million | $14.18 Million | $58.46 Million | — |